Ursodeoxycholic acid treatment for primary sclerosing cholangitis

被引：0

作者：

Mol, Bregje ^{[1
]}

van Munster, Kim ^{[1
]}

Weersma, Rinse ^{[2
,3
]}

Inderson, Akin ^{[4
]}

Boonstra, Kirsten ^{[5
]}

Drenth, Joost P. H. ^{[1
]}

van Meer, Suzanne ^{[6
]}

de Vries, Elsemieke S. ^{[7
]}

Spanier, B. W. Marcel ^{[8
]}

Vrij, Ton ^{[9
]}

Verlaan, Tess ^{[10
]}

van Duijn, Femke ^{[1
]}

Ponsioen, Willemijn ^{[1
]}

Beuers, Ulrich ^{[1
]}

Dijkgraaf, Marcel ^{[1
]}

Ponsioen, Cyriel ^{[1
]}

机构：

[1] Univ Amsterdam, Med Ctr, Amsterdam, Netherlands

[2] Univ Groningen, Groningen, Netherlands

[3] Univ Med Ctr Groningen, Groningen, Netherlands

[4] Leiden Univ, Med Ctr, Leiden, Netherlands

[5] Radboud Univ Nijmegen, Med Ctr, Nijmegen, Netherlands

[6] Univ Med Ctr Utrecht, Utrecht, Netherlands

[7] Isala Clin, Zwolle, Netherlands

[8] Rijnstate Hosp, Arnhem, Netherlands

[9] Zorggroep Twente, Almelo, Netherlands

[10] Gelderse Vallei Hosp, Ede, Netherlands

来源：

JOURNAL OF HEPATOLOGY | 2024年 / 80卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

THU-115-YI

引用

页码：S317 / S317

页数：1

共 50 条

[41] RESOLUTION OF RADIOGRAPHIC ABNORMALITIES WITH URSODEOXYCHOLIC ACID THERAPY OF PRIMARY SCLEROSING CHOLANGITIS
LEBOVICS, E
SALAMA, M
ELHOSSEINY, A
ROSENTHAL, WS
GASTROENTEROLOGY, 1992, 102 (06) : 2143 - 2147
[42] Primary sclerosing cholangitis: neoplastic potential and chemopreventive effect of ursodeoxycholic acid
Stiehl, A
Rost, D
Gastroenterology Yesterday - Today - Tomorrow: A Review and Preview, 2005, 144 : 196 - 202
[43] PRIMARY SCLEROSING CHOLANGITIS What is the role of ursodeoxycholic acid in therapy for PSC?
Chapman, Roger W.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2010, 7 (02) : 74 - 75
[44] Prospective Evaluation of Ursodeoxycholic Acid Withdrawal in Patients With Primary Sclerosing Cholangitis
Wunsch, Ewa
Trottier, Jocelyn
Milkiewicz, Malgorzata
Raszeja-Wyszomirska, Joanna
Hirschfield, Gideon M.
Barbier, Olivier
Milkiewicz, Piotr
HEPATOLOGY, 2014, 60 (03) : 931 - 940
[45] High-dose ursodeoxycholic acid in the management of primary sclerosing cholangitis
Chapman, RW
BILE ACID BIOLOGY AND ITS THERAPEUTIC IMPLICATIONS, 2005, 141 : 230 - 241
[46] Are there patients with primary sclerosing cholangitis in whom ursodeoxycholic acid may be beneficial?
Kim, WR
Jorgensen, RA
Malinchoc, M
Benson, JT
Dickson, ER
Lindor, KD
GASTROENTEROLOGY, 1997, 112 (04) : A1301 - A1301
[47] High-dose ursodeoxycholic acid in the management of primary sclerosing cholangitis
Chapman, RW
BILE ACIDS: FROM GENOMICS TO DISEASE AND THERAPY, 2003, 129 : 240 - 251
[48] URSODEOXYCHOLIC ACID FOR THE TREATMENT OF PRIMARY SCLEROSING CHOLANGITIS - A 30-MONTH PILOT-STUDY
OBRIEN, CB
SENIOR, JR
ARORAMIRCHANDANI, R
BATTA, AK
SALEN, G
HEPATOLOGY, 1991, 14 (05) : 838 - 847
[49] The incidence of cholangiocarcinoma in primary sclerosing cholangitis after long-time treatment with ursodeoxycholic acid
Rudolph, Gerda
Kloeters-Plachky, Petra
Rost, Daniel
Stiehl, Adolf
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2007, 19 (06) : 487 - 491
[50] EFFECT OF URSODEOXYCHOLIC ACID ON BILE-ACID METABOLISM IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS
RUDOLPH, G
STIEHL, A
RAEDSCH, R
WALKER, S
HEPATOLOGY, 1990, 12 (02) : 439 - 439

← 1 2 3 4 5 →